SCHEMBL14469569

SCHEMBL14469569

C=C/C=C(\C=C/N)CN1CCC(C(=O)N2CCN(Cc3ccccc3Cl)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.47
▸ ALDH1A2 O94788 1/20 0.47
▸ ALDH2 P05091 1/20 0.47
▸ ALDH3A1 P30838 1/20 0.47
▸ ALDH1A3 P47895 1/20 0.47
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ TSHR P16473 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ CXCR4 P61073 1/20 0.44
▸ FAAH O00519 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14469560 0.90 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ATSHRSMN1; SMN2
SCHEMBL14469451 0.90 TSHR (0.46) ALDH1A1MEN1KMT2ATSHRSMN1; SMN2
SCHEMBL14469477 0.89 KMT2A (0.58) ALDH1A1MEN1KMT2ATSHRSMN1; SMN2
SCHEMBL14469188 0.89 ALDH1A1 (0.46) ALDH1A1ALDH1A2ALDH2ALDH3A1ALDH1A3
SCHEMBL14469473 0.89 KMT2A (0.43) ALDH1A1MEN1KMT2ATSHRSMN1; SMN2
SCHEMBL14469554 0.88 SMN1; SMN2 (0.40) ALDH1A1ALDH1A2ALDH2ALDH3A1ALDH1A3
SCHEMBL14469461 0.88 HDAC1 (0.46) MEN1KMT2ATSHRSMN1; SMN2ALOX15
SCHEMBL14469551 0.87 KDM4E (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2ALOX15
SCHEMBL14469478 0.86 SMN1; SMN2 (0.43) ALDH1A1CYP3A4CYP2D6MEN1KMT2A
SCHEMBL14469460 0.86 KMT2A (0.51) ALDH1A1MEN1KMT2ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007075555-A2 COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT SCHERING CORPORATION (US) 2007-07-05 — — WO disclosed
Send feedback